We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Estradiol Transdermal System 37.5mcg/day (0.0375mg/day) (Sandoz, USA)
Section 19A approved medicine
Estradiol Transdermal System 37.5mcg/day (0.0375mg/day) (Sandoz, USA)
Section 19A approval holder
Sandoz Pty Ltd ABN 60 754 449 553
Phone
1800 726 369
Approved until
Status
Current
Medicines in short supply/unavailable
ESTRADOT 37.5 estradiol 37.5 microgram transdermal drug delivery system sachet - ARTG 338057
Indication(s)
Short term treatment of symptoms of estrogen deficiency due to the menopause, whether natural or surgically induced. In women with an intact uterus, estrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.
Images
